OMAHA, Neb. (WOWT) - First Alert 6 has the headlines you need to know to get your Monday started. A North Omaha home is in ...

Execute a pivotal program for potential best-in-class BTK degrader, bexobrutideg, including Phase 2 and confirmatory Phase 3 studies to support ...

Global cancer cases have surged dramatically, doubling since 1990 and reaching 18.5 million new diagnoses in 2023. Deaths ...

As we ring in the new year, cancer survivors on the island of St. Croix can continue to look forward to art classes and other ...

TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...

Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...

SELLAS Life Sciences Virtual R&D Day – October 29, 2025: Advancing Novel Therapies in Acute Myeloid Leukemia (AML): An Overview of the Ongoing Phase 3 REGAL Trial of Galinpepimut-S (GPS) and SLS009 ...

This interview is the second extended discussion between Professor Reiss and the World Socialist Web Site examining the accelerating assault on vaccines and public health in the United States.

The past year in Sartell, 2025, was in many ways a historic landmark year because of many major progressive developments.

Electronic data capture (EDC) extract from the ongoing ACR-368 registrational-intent Phase 2b monotherapy trial in OncoSignature-positive (BM+) subjects with endometrial cancer (EC) showed 39% overall ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads today ...

"When she became first lady, she took a back seat. But for many, she is the power behind the throne or a top adviser," said Carmen Arteaga, a doctor of political science.